» Articles » PMID: 23836199

A Brighter Future in the Fight Against Hepatitis

Overview
Journal Nat Med
Date 2013 Jul 10
PMID 23836199
Citations 1
Affiliations
Soon will be listed here.
Abstract

Public health and research efforts directed at managing and targeting viral hepatitis have borne fruit in recent decades. However, more work is necessary to meet the goals of preventing transmission and treating infection to eliminate the enormous burden of hepatitis worldwide.

Citing Articles

Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.

Hill A, Khoo S, Fortunak J, Simmons B, Ford N Clin Infect Dis. 2014; 58(7):928-36.

PMID: 24399087 PMC: 3952605. DOI: 10.1093/cid/ciu012.

References
1.
Denniston M, Klevens R, McQuillan G, Jiles R . Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology. 2012; 55(6):1652-61. PMC: 4586034. DOI: 10.1002/hep.25556. View

2.
Janssen H, Reesink H, Lawitz E, Zeuzem S, Rodriguez-Torres M, Patel K . Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013; 368(18):1685-94. DOI: 10.1056/NEJMoa1209026. View

3.
Jacobson I, Gordon S, Kowdley K, Yoshida E, Rodriguez-Torres M, Sulkowski M . Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med. 2013; 368(20):1867-77. DOI: 10.1056/NEJMoa1214854. View